Centralized access to cancer registries

The Food and Drug Administration and National Cancer Institute will have enhanced abilities to perform high-quality postmarket surveillance and other research at lower cost and with faster speed. This system also seeks to reduce cost and burden by participating state cancer registries. This process also supports the current modifications proposed by the U.S. Department of Health and Human Services and 15 other Federal Departments and Agencies to modernize, strengthen, and make more effective the Federal Policy for the Protection of Human Subjects known as the Common Rule.